Anti-Fibrotic Activity of Hepion Pharmaceuticals' CRV431 Shows Potential to Extend to Multiple Organs and Fibrotic Diseases

Stock Information for Hepion Pharmaceuticals Inc.

Loading

Please wait while we load your information from QuoteMedia.